Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Thomas

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Cancer Research Communications|November 16, 2022
Replication stress defines distinct molecular subtypes across cancersNobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, et al.
Journal of Clinical Medicine|February 11, 2023
Clinicopathological and Treatment Patterns of Combined Small-Cell Lung Carcinoma with Future Insight to Treatment: A Population-Based StudyAsad Ullah, Omer Saeed, Nabin Raj Karki, et al.
Computational and Structural Biotechnology Journal|June 30, 2025
SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasmsKolos Nemes, Gabriella Mihalekné Fűr, Alexandra Benő, et al.
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2020
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumorsKeith T Schmidt, Alwin D R Huitema, Thomas P C Dorlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.
Biorxiv : the Preprint Server for Biology|September 19, 2025
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung CancerAzam Ghafoor, Linying Zhu, Zoe Weaver Ohler, et al.
Molecular Cancer Therapeutics|May 28, 2021
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging AgentsUkhyun Jo, Ilya S Senatorov, Astrid Zimmermann, et al.
Cold Spring Harbor Molecular Case Studies|October 8, 2020
Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumorsNobuyuki Takahashi, Vinodh N Rajapakse, Lorinc Pongor, et al.
Cell Reports|August 19, 2023
Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapySudipta Biswas, Kai Kang, Kwok Peng Ng, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Cancer Research Communications|November 16, 2022
Replication stress defines distinct molecular subtypes across cancersNobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, et al.
Journal of Clinical Medicine|February 11, 2023
Clinicopathological and Treatment Patterns of Combined Small-Cell Lung Carcinoma with Future Insight to Treatment: A Population-Based StudyAsad Ullah, Omer Saeed, Nabin Raj Karki, et al.
Computational and Structural Biotechnology Journal|June 30, 2025
SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasmsKolos Nemes, Gabriella Mihalekné Fűr, Alexandra Benő, et al.
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2020
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumorsKeith T Schmidt, Alwin D R Huitema, Thomas P C Dorlo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.
Biorxiv : the Preprint Server for Biology|September 19, 2025
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung CancerAzam Ghafoor, Linying Zhu, Zoe Weaver Ohler, et al.
Molecular Cancer Therapeutics|May 28, 2021
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging AgentsUkhyun Jo, Ilya S Senatorov, Astrid Zimmermann, et al.
Cold Spring Harbor Molecular Case Studies|October 8, 2020
Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumorsNobuyuki Takahashi, Vinodh N Rajapakse, Lorinc Pongor, et al.
Cell Reports|August 19, 2023
Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapySudipta Biswas, Kai Kang, Kwok Peng Ng, et al.
Pageof 17